Treatment Based on High Precision Cardiac Mapping

APOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Mapping (EAM) to support Ventricular tachycardia (VT) ablation targeting and verification.

NCT Number	NCT07746336
Lead Sponsor	Hospital Clinic of Barcelona
Conditions	VT Ablation, Arrhythmic Burden, Implantable Cardioverter-Defibrillator (ICD) Therapies, Slow-conduction Substrate
Enrollment	60 participants
Start Date	2026-07-15
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-05